TimesSquare Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-429,510
Closed -$30.3M 193
2022
Q3
$30.3M Buy
429,510
+26,980
+7% +$2.31M 0.42% 113
2022
Q2
$28.6M Buy
402,530
+96,230
+31% +$6.2M 0.4% 115
2022
Q1
$24.5M Sell
306,300
-43,900
-13% -$3.27M 0.27% 138
2021
Q4
$32M Buy
350,200
+205,140
+141% +$22M 0.28% 143
2021
Q3
$18.6M Sell
145,060
-16,160
-10% -$2.26M 0.16% 177
2021
Q2
$24.6M Sell
161,220
-112,410
-41% -$14.8M 0.2% 169
2021
Q1
$28.8M Sell
273,630
-164,870
-38% -$16.5M 0.25% 153
2020
Q4
$34.7M Sell
438,500
-116,800
-21% -$8.55M 0.28% 141
2020
Q3
$31.4M Sell
555,300
-60,700
-10% -$3.27M 0.29% 143
2020
Q2
$37.9M Sell
616,000
-213,600
-26% -$8.73M 0.36% 123
2020
Q1
$26.8M Sell
829,600
-51,900
-6% -$1.75M 0.32% 132
2019
Q4
$31M Sell
881,500
-116,300
-12% -$3.84M 0.28% 148
2019
Q3
$25.7M Sell
997,800
-23,200
-2% -$705K 0.23% 159
2019
Q2
$30M Buy
+1,021,000
New +$29.5M 0.23% 149

Other funds holding STAA

TimesSquare Capital Management's STAA Position: Q4 2022 in Review

TimesSquare Capital Management sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 429,510 shares — an estimated $30.3M sold.

TimesSquare Capital Management first reported a position in STAA in Q2 2019 and held it in 14 quarters. The position peaked at $37.9M in Q2 2020. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • TimesSquare Capital Management reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 429,510 STAAR Surgical shares in Q4 2022, an estimated $30.3M.
  • TimesSquare Capital Management first reported a position in STAAR Surgical in Q2 2019 and held it in 14 quarters.
  • TimesSquare Capital Management's STAAR Surgical position peaked at $37.9M in Q2 2020.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on TimesSquare Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.